NCT03357263

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults

Randomized, Single-Blind, Active Comparator-controlled Study to Evaluate the Safety and Immunological Efficacy of GC3114 in Healthy Adults.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Green Cross Corporation · Industry
• Sex: All
• Age: 19 Years – 64 Years
• Healthy volunteers: Accepted

Summary

Healthy adults will be once administered GC3114A(High-dose Quadrivalent influenza vaccine) or GCFLU Quadrivalent Pre-filled syringe inj..

Detailed description

Healthy adults will be once administered GC3114A(High-dose Quadrivalent influenza vaccine) or GCFLU Quadrivalent Pre-filled syringe inj.. Safety and immunological efficacy will be evaluated.

Conditions

• Influenza, Human

Interventions

Type	Name	Description
BIOLOGICAL	GC3114	High-dose Quadrivalent influenza vaccine
BIOLOGICAL	GCFLU Quadrivalent	Quadrivalent influenza vaccine

Timeline

• Start date: 2017-11-20
• Primary completion: 2017-12-22
• Completion: 2017-12-22
• First posted: 2017-11-29
• Last updated: 2018-11-19

Locations

1 site across 1 country: South Korea